1. Melo M, da Rocha AG, Vinagre J, Sobrinho-Simões M, Soares P

Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33: 667-8, 2015.  [Letter] 

 doi: 10.1200/JCO.2014.59.4614 PMID: 25605839.

 

2. Boaventura P, Soares P, Pereira D, Teixeira-Gomes J, Sobrinho-Simões M

Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment. The Lancet infectious diseases 11: 163-4, 2011.  [Letter] 

 doi: 10.1016/S1473-3099(11)70047-0 PMID: 21371653.

 

3. Máximo V, Soares P, Machado JC, Seruca R, Sobrinho-Simões M

Mitochondrial DNA alteration in gastric cancer. Gastroenterology 119: 1808-9, 2000.  [Letter] 

 PMID: 11187439.

 

4. Pópulo H, Lopes JM, Sobrinho-Simões M, Soares P

RE: TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. Journal of the National Cancer Institute 107: 1, 2015.  [Letter] 

 doi: 10.1093/jnci/djv049 PMID: 25755155.

 

5. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P

Frequency of TERT promoter mutations in human cancers. Nature communications 4: 2185, 2013.  [Article] 

 doi: 10.1038/ncomms3185 PMID: 23887589.

 

6. Correia M, Pinheiro P, Batista R, Soares P, Sobrinho-Simões M, Máximo V

Etiopathogenesis of oncocytomas. Seminars in cancer biology 47: 82-94, 2017.  [Review] 

 doi: 10.1016/j.semcancer.2017.06.014 PMID: 28687249.

 

7. Soares P, Sobrinho-Simões M

Cancer: Small papillary thyroid cancers--is BRAF of prognostic value? Nature reviews. Endocrinology 7: 9-10, 2011.  [Editorial Material] 

 doi: 10.1038/nrendo.2010.213 PMID: 21160471.

 

8. Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simões M, Lima J, Máximo V, Soares P, Lyden D, Bromberg JF

STAT3 negatively regulates thyroid tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 109: E2361-70, 2012.  [Article] 

 doi: 10.1073/pnas.1201232109 PMID: 22891351.

 

9. Santos LR, Durães C, Ziros PG, Pestana A, Esteves C, Neves C, Carvalho D, Bongiovanni M, Renaud CO, Chartoumpekis DV, Habeos IG, Simões MS, Soares P, Sykiotis GP

Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto's Thyroiditis. Thyroid : official journal of the American Thyroid Association 29: 1302-1315, 2019.  [Article] 

 doi: 10.1089/thy.2018.0480 PMID: 31426718.

 

10. Lesueur F, Corbex M, McKay JD, Lima J, Soares P, Griseri P, Burgess J, Ceccherini I, Landolfi S, Papotti M, Amorim A, Goldgar DE, Romeo G

Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. Journal of medical genetics 39: 260-5, 2002.  [Article] 

 PMID: 11950855.

 

11. Pópulo H, Boaventura P, Vinagre J, Batista R, Mendes A, Caldas R, Pardal J, Azevedo F, Honavar M, Guimarães I, Manuel Lopes J, Sobrinho-Simões M, Soares P

TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation. The Journal of investigative dermatology 134: 2251-7, 2014.  [Article] 

 doi: 10.1038/jid.2014.163 PMID: 24691053.

 

12. Campos MA, Macedo S, Fernandes M, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P

TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 80: 660-669.e6, 2019.  [Article] 

 doi: 10.1016/j.jaad.2018.08.032 PMID: 30165166.

 

13. Máximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simões M

Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. The American journal of pathology 160: 1857-65, 2002.  [Article] 

 PMID: 12000737.

 

14. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-8, 2001.  [Article] 

 doi: 10.1038/sj.onc.1204234 PMID: 11313896.

 

15. Castro P, Soares P, Gusmão L, Seruca R, Sobrinho-Simões M

H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid. Oncogene 25: 4620-7, 2006.  [Article] 

 doi: 10.1038/sj.onc.1209491 PMID: 16532025.

 

16. Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. International journal of cancer 139: 414-23, 2016.  [Article] 

 doi: 10.1002/ijc.30057 PMID: 26914704.

 

17. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22: 4578-80, 2003.  [Article] 

 doi: 10.1038/sj.onc.1206706 PMID: 12881714.

 

18. Faustino A, Couto JP, Pópulo H, Rocha AS, Pardal F, Cameselle-Teijeiro JM, Lopes JM, Sobrinho-Simões M, Soares P

mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism 97: E1139-49, 2012.  [Article] 

 doi: 10.1210/jc.2011-2748 PMID: 22549934.

 

19. Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, Gomes D, Cameselle-Teijeiro J, Vidal A, Martins TC, Sobrinho-Simões M, Soares P

Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene 30: 1302-17, 2011.  [Article] 

 doi: 10.1038/onc.2010.512 PMID: 21057533.

 

20. Melo M, Costa G, Ribeiro C, Carrilho F, Martins MJ, da Rocha AG, Sobrinho-Simões M, Carvalheiro M, Soares P

Stimulated Thyroglobulin at Recombinant Human TSH-Aided Ablation Predicts Disease-free Status One Year Later. The Journal of clinical endocrinology and metabolism 98: 4364-72, 2013.  [Article] 

 doi: 10.1210/jc.2013-2267 PMID: 24037891.

 

21. Ziros PG, Manolakou SD, Habeos IG, Lilis I, Chartoumpekis DV, Koika V, Soares P, Kyriazopoulou VE, Scopa CD, Papachristou DJ, Sykiotis GP

Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells. The Journal of clinical endocrinology and metabolism 98: E1422-7, 2013.  [Article] 

 doi: 10.1210/jc.2013-1510 PMID: 23766517.

 

22. Castro P, Eknaes M, Teixeira MR, Danielsen HE, Soares P, Lothe RA, Sobrinho-Simões M

Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes. The Journal of pathology 206: 305-11, 2005.  [Article] 

 doi: 10.1002/path.1772 PMID: 15852498.

 

23. Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism 99: E754-65, 2014.  [Article] 

 doi: 10.1210/jc.2013-3734 PMID: 24476079.

 

24. Santos LR, Durães C, Mendes A, Prazeres H, Alvelos MI, Moreira CS, Canedo P, Esteves C, Neves C, Carvalho D, Sobrinho-Simões M, Soares P

A Polymorphism in the Promoter Region of the Selenoprotein S Gene (SEPS1) Contributes to Hashimoto's Thyroiditis Susceptibility. The Journal of clinical endocrinology and metabolism 99: E719-23, 2014.  [Article] 

 doi: 10.1210/jc.2013-3539 PMID: 24471570.

 

25. Nunes JB, Peixoto J, Soares P, Maximo V, Carvalho S, Pinho SS, Vieira AF, Paredes J, Rego AC, Ferreira IL, Gomez-Lazaro M, Sobrinho-Simoes M, Singh KK, Lima J

OXPHOS dysfunction regulates integrin-ß1 modifications and enhances cell motility and migration. Human molecular genetics 24: 1977-90, 2015.  [Article] 

 doi: 10.1093/hmg/ddu612 PMID: 25504047.

 

26. Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simões M

Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases. The American journal of surgical pathology 41: 854-860, 2017.  [Article] 

 doi: 10.1097/PAS.0000000000000793 PMID: 28009606.

 

27. Lima J, Teixeira-Gomes J, Soares P, Máximo V, Honavar M, Williams D, Sobrinho-Simões M

Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. The Journal of clinical endocrinology and metabolism 88: 4932-7, 2003.  [Article] 

 PMID: 14557476.

 

28. Castro P, Vieira de Castro I, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism 91: 213-20, 2006.  [Article] 

 doi: 10.1210/jc.2005-1336 PMID: 16219715.

 

29. Melo M, Gaspar da Rocha A, Batista R, Vinagre J, Martins MJ, Costa G, Ribeiro C, Carrilho F, Leite V, Lobo C, Cameselle-Teijeiro JM, Cavadas B, Pereira L, Sobrinho-Simões M, Soares P

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease. The Journal of clinical endocrinology and metabolism 102: 1898-1907, 2017.  [Article] 

 doi: 10.1210/jc.2016-2785 PMID: 28323937.

 

30. Lima J, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simões M

BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. The Journal of clinical endocrinology and metabolism 89: 4267-71, 2004.  [Article] 

 doi: 10.1210/jc.2003-032224 PMID: 15356020.

 

31. Rocha AS, Paternot S, Coulonval K, Dumont JE, Soares P, Roger PP

Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation. Molecular biology of the cell 19: 4814-25, 2008.  [Article] 

 doi: 10.1091/mbc.E08-06-0617 PMID: 18799615.

 

32. Gonçalves AP, Máximo V, Lima J, Singh KK, Soares P, Videira A

Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH  1813: 492-9, 2011.  [Article] 

 doi: 10.1016/j.bbamcr.2011.01.006 PMID: 21223980.

 

33. Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M

BRAF mutations are associated with some histological types of papillary thyroid carcinoma. The Journal of pathology 202: 247-51, 2004.  [Article] 

 doi: 10.1002/path.1511 PMID: 14743508.

 

34. Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M

The biology and the genetics of Hurthle cell tumors of the thyroid. Endocrine-related cancer 19: R131-47, 2012.  [Review] 

 doi: 10.1530/ERC-11-0354 PMID: 22514109.

 

35. Ferreira LB, Tavares C, Pestana A, Pereira CL, Eloy C, Pinto MT, Castro P, Batista R, Rios E, Sobrinho-Simões M, Gimba ER, Soares P

Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior. Oncotarget 7: 52003-52016, 2016.  [Article] 

 doi: 10.18632/oncotarget.10468 PMID: 27409830.

 

36. Preto A, Figueiredo J, Velho S, Ribeiro AS, Soares P, Oliveira C, Seruca R

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations. The Journal of pathology 214: 320-7, 2008.  [Article] 

 doi: 10.1002/path.2295 PMID: 18098337.

 

37. Rocha AS, Soares P, Seruca R, Máximo V, Matias-Guiu X, Cameselle-Teijeiro J, Sobrinho-Simões M

Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. The Journal of pathology 194: 358-66, 2001.  [Article] 

 doi: 10.1002/path.905 PMID: 11439369.

 

38. Pópulo H, Soares P, Faustino A, Rocha AS, Silva P, Azevedo F, Lopes JM

mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics. Pigment cell & melanoma research 24: 254-7, 2011.  [Letter] 

 doi: 10.1111/j.1755-148X.2010.00796.x PMID: 21029395.

 

39. Martins RG, Nunes JB, Máximo V, Soares P, Peixoto J, Catarino T, Rito T, Soares P, Pereira L, Sobrinho-Simões M, Santos AP, Couto J, Henrique R, Matos-Loureiro J, Dias P, Torres I, Lima J

A founder SDHB mutation in Portuguese paraganglioma patients. Endocrine-related cancer 20: L23-6, 2013.  [Letter] 

 doi: 10.1530/ERC-12-0399 PMID: 24092654.

 

40. Pópulo H, Caldas R, Lopes JM, Pardal J, Máximo V, Soares P

Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy. Expert opinion on therapeutic targets 19: 733-45, 2015.  [Article] 

 doi: 10.1517/14728222.2015.1045416 PMID: 25976231.

 

41. Flores C, Lima RT, Adessi A, Sousa A, Pereira SB, Granja PL, De Philippis R, Soares P, Tamagnini P

Characterization and antitumor activity of the extracellular carbohydrate polymer from the cyanobacterium Synechocystis ¿sigF mutant. International journal of biological macromolecules 136: 1219-1227, 2019.  [Article] 

 doi: 10.1016/j.ijbiomac.2019.06.152 PMID: 31233798.

 

42. Lima J, Máximo V, Soares P, Williams D, Bogdanova T, Thomas GA, Sobrinho-Simões M

Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582. Carcinogenesis 24: 1155, 2003.  [Letter] 

 doi: 10.1093/carcin/bgg050 PMID: 12807747.

 

43. Campanella NC, Celestino R, Pestana A, Scapulatempo-Neto C, de Oliveira AT, Brito MJ, Gouveia A, Lopes JM, Guimarães DP, Soares P, Reis RM

Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs). European journal of human genetics : EJHG 23: 877-9, 2015.  [Article] 

 doi: 10.1038/ejhg.2014.195 PMID: 25248398.

 

44. Lado-Abeal J, Celestino R, Bravo SB, Garcia-Rendueles ME, de la Calzada J, Castro I, Castro P, Espadinha C, Palos F, Soares P, Alvarez CV, Sobrinho-Simões M, Cameselle-Teijeiro J

Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor. Endocrine-related cancer 17: 599-610, 2010.  [Article] 

 doi: 10.1677/ERC-09-0069 PMID: 20427420.

 

45. Máximo V, Soares P, Seruca R, Rocha AS, Castro P, Sobrinho-Simões M

Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes, chromosomes & cancer 32: 136-43, 2001.  [Article] 

 PMID: 11550281.

 

46. Andrade MN, Santos-Silva AP, Rodrigues-Pereira P, Paiva-Melo FD, de Lima Junior NC, Teixeira MP, Soares P, Dias GRM, Graceli JB, de Carvalho DP, Ferreira ACF, Miranda-Alves L

The environmental contaminant tributyltin leads to abnormalities in different levels of the hypothalamus-pituitary-thyroid axis in female rats. Environmental pollution (Barking, Essex : 1987) 241: 636-645, 2018.  [Article] 

 doi: 10.1016/j.envpol.2018.06.006 PMID: 29902746.

 

47. Boaventura P, Bastos J, Pereira D, Soares P, Teixeira-Gomes JM

Alopecia in women submitted to childhood X-ray epilation for tinea capitis treatment. The British journal of dermatology 163: 643-4, 2010.  [Letter] 

 doi: 10.1111/j.1365-2133.2010.09846.x PMID: 20456347.

 

48. Boaventura P, Batista R, Pestana A, Reis M, Mendes A, Eloy C, Sobrinho-Simões M, Soares P

TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation. European journal of endocrinology 176: 49-55, 2017.  [Article] 

 doi: 10.1530/EJE-16-0740 PMID: 27760791.

 

49. Vinagre J, Nabais J, Pinheiro J, Batista R, Oliveira RC, Gonçalves AP, Pestana A, Reis M, Mesquita B, Pinto V, Lyra J, Cipriano MA, Ferreira MG, Lopes JM, Sobrinho-Simões M, Soares P

TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes. Scientific reports 6: 29714, 2016.  [Article] 

 doi: 10.1038/srep29714 PMID: 27411289.

 

50. Pinto M, Soares P, Ribatti D

Thyroid hormone as a regulator of tumor induced angiogenesis. Cancer letters 301: 119-26, 2011.  [Review] 

 doi: 10.1016/j.canlet.2010.11.011 PMID: 21183275.

 

51. Celestino R, Lima J, Faustino A, Vinagre J, Máximo V, Gouveia A, Soares P, Lopes JM

Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. European journal of human genetics : EJHG 21: 503-10, 2013.  [Article] 

 doi: 10.1038/ejhg.2012.205 PMID: 22948025.

 

52. Lima J, Máximo V, Soares P, Sobrinho-Simões M

Alterations of the SDHD gene locus in midgut carcinoids. Genes, chromosomes & cancer 36: 424, 2003.  [Letter] 

 doi: 10.1002/gcc.10147 PMID: 12619155.

 

53. Pópulo H, Soares P, Lopes JM

Insights into melanoma: targeting the mTOR pathway for therapeutics. Expert opinion on therapeutic targets 16: 689-705, 2012.  [Review] 

 doi: 10.1517/14728222.2012.691472 PMID: 22620498.

 

54. Costa BM, Viana-Pereira M, Fernandes R, Costa S, Linhares P, Vaz R, Pinheiro C, Lima J, Soares P, Silva A, Pardal F, Amorim J, Nabiço R, Almeida R, Alegria C, Pires MM, Pinheiro C, Carvalho E, Oliveira P, Lopes JM, Reis RM

Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20: 2610-7, 2011.  [Article] 

 doi: 10.1158/1055-9965.EPI-11-0340 PMID: 21960689.

 

55. Máximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simões M

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. British journal of cancer 92: 1892-8, 2005.  [Article] 

 doi: 10.1038/sj.bjc.6602547 PMID: 15841082.

 

56. Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M

ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome. European journal of endocrinology 174: R117-26, 2016.  [Review] 

 doi: 10.1530/EJE-15-0605 PMID: 26510840.

 

57. Ferreira LB, Eloy C, Pestana A, Lyra J, Moura M, Prazeres H, Tavares C, Sobrinho-Simões M, Gimba E, Soares P

Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma. European journal of endocrinology 174: 551-61, 2016.  [Article] 

 doi: 10.1530/EJE-15-0577 PMID: 26811408.

 

58. Lyra J, Vinagre J, Batista R, Pinto V, Prazeres H, Rodrigues F, Eloy C, Sobrinho-Simões M, Soares P

mTOR activation in medullary thyroid carcinoma with RAS mutation. European journal of endocrinology 171: 633-40, 2014.  [Article] 

 doi: 10.1530/EJE-14-0389 PMID: 25163725.

 

59. Carvalho R, Kayademir T, Soares P, Canedo P, Sousa S, Oliveira C, Leistenschneider P, Seruca R, Gött P, Blin N, Carneiro F, Machado JC

Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Laboratory investigation; a journal of technical methods and pathology 82: 1319-26, 2002.  [Article] 

 PMID: 12379766.

 

60. Tavares C, Coelho MJ, Melo M, da Rocha AG, Pestana A, Batista R, Salgado C, Eloy C, Ferreira L, Rios E, Sobrinho-Simões M, Soares P

pmTOR is a marker of aggressiveness in papillary thyroid carcinomas. Surgery 160: 1582-1590, 2016.  [Article] 

 doi: 10.1016/j.surg.2016.06.050 PMID: 27574774.

 

61. Castro L, Alves S, Chaves SR, Costa JL, Soares P, Preto A

RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation. Molecular and cellular endocrinology 415: 64-75, 2015.  [Article] 

 doi: 10.1016/j.mce.2015.08.006 PMID: 26265449.

 

62. Celestino R, Magalhães J, Castro P, Triller M, Vinagre J, Soares P, Sobrinho-Simões M

A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology 55: 482-7, 2009.  [Letter] 

 doi: 10.1111/j.1365-2559.2009.03401.x PMID: 19817905.

 

63. Couto JP, Almeida A, Daly L, Sobrinho-Simões M, Bromberg JF, Soares P

AZD1480 Blocks Growth and Tumorigenesis of RET- Activated Thyroid Cancer Cell Lines. PloS one 7: e46869, 2012.  [Article] 

 doi: 10.1371/journal.pone.0046869 PMID: 23056499.

 

64. Portovedo S, Gaido N, de Almeida Nunes B, Nascimento AG, Rocha A, Magalhães M, Nascimento GC, Pires de Carvalho D, Soares P, Takiya C, Faria MDS, Miranda-Alves L

Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors. Molecular and cellular endocrinology 490: 80-87, 2019.  [Article] 

 doi: 10.1016/j.mce.2019.04.010 PMID: 30999005.

 

65. Máximo V, Lima J, Soares P, Silva A, Bento I, Sobrinho-Simões M

GRIM-19 in Health and Disease. Advances in anatomic pathology 15: 46-53, 2008.  [Editorial Material] 

 doi: 10.1097/PAP.0b013e31815e5258 PMID: 18156812.

 

66. Ferreira LB, Lima RT, Bastos ACSDF, Silva AM, Tavares C, Pestana A, Rios E, Eloy C, Sobrinho-Simões M, Gimba ERP, Soares P

OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19102990 PMID: 30274371.

 

67. Tavares C, Eloy C, Melo M, Gaspar da Rocha A, Pestana A, Batista R, Bueno Ferreira L, Rios E, Sobrinho Simões M, Soares P

mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19051448 PMID: 29757257.

 

68. Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-Gomes J, Sobrinho-Simões M, Soares P

MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. European journal of endocrinology 168: 119-28, 2013.  [Article] 

 doi: 10.1530/EJE-12-0327 PMID: 23093699.

 

69. Boaventura P, Pereira D, Celestino R, Mendes A, Nakasawa T, Teixeira-Gomes J, Sobrinho-Simões M, Soares P

Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment. European journal of endocrinology 169: 673-679, 2013.  [Article] 

 doi: 10.1530/EJE-13-0543 PMID: 23966419.

 

70. Cárcano FM, Vidal DO, van Helvoort Lengert A, Neto CS, Queiroz L, Marques H, Baltazar F, da Silva Martinelli CM, Soares P, da Silva EC, Lopes LF, Reis RM

Hotspot TERT promoter mutations are rare events in testicular germ cell tumors. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 37: 4901-7, 2016.  [Article] 

 doi: 10.1007/s13277-015-4317-y PMID: 26526580.

 

71. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P, Reis-Filho JS, Reyes-Santías RM, Alfonsín-Barreiro N, Forteza J, Sobrinho-Simões M

Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 17: 819-26, 2004.  [Article] 

 doi: 10.1038/modpathol.3800124 PMID: 15044923.

 

72. Moreira S, Correia M, Soares P, Máximo V

GRIM-19 function in cancer development. Mitochondrion 11: 693-9, 2011.  [Review] 

 doi: 10.1016/j.mito.2011.05.011 PMID: 21664299.

 

73. Amorim JP, Santos G, Vinagre J, Soares P

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype. Genes 7: 1, 2016.  [Review] 

 doi: 10.3390/genes7090066 PMID: 27657132.

 

74. Saieg MA, Cury AN, Oliveira AK, Nascimento AO, Melo M, Soares P, Sobrinho-Simões M

Study of the histological profile of papillary thyroid carcinoma associated to hashimoto thyroiditis Histopathology  192, 2010.  [Meeting Abstract] 

.

 

75. Alvarenga CA, Vinagre J, Paravidino PI, Alvarenga MA, Billish A, Castilho LN, Prando A, Soares P, Lopes JM

Paraganglioma of vesicle seminal and chromophobe renal cell carcinoma: a rare sporadic or hereditary association? Histopathology  243, 2010.  [Meeting Abstract] 

.

 

76. Celestino R, Sigstad E, Løvf M, Thomassen GO, Grøholt KK, Jørgensen LH, Berner A, Castro P, Lothe RA, Bjøro T, Sobrinho-Simões M, Soares P, Skotheim RI

Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes. Genes, chromosomes & cancer 51: 1154-64, 2012.  [Article] 

 doi: 10.1002/gcc.22003 PMID: 22961909.

 

77. Berto-Júnior C, de Carvalho DP, Soares P, Miranda-Alves L

Tributyltin and Zebrafish: Swimming in Dangerous Water. Frontiers in endocrinology 9: 152, 2018.  [Review] 

 doi: 10.3389/fendo.2018.00152 PMID: 29692757.

 

78. Batista R, Vinagre J, Prazeres H, Sampaio C, Peralta P, Conceição P, Sismeiro A, Leão R, Gomes A, Furriel F, Oliveira C, Torres JN, Eufrásio P, Azinhais P, Almeida F, Gonzalez ER, Bidovanets B, Ecke T, Stinjs P, Pascual ÁS, Abdelmalek R, Villafruela A, Beardo-Villar P, Fidalgo N, Öztürk H, Gonzalez-Enguita C, Monzo J, Lopes T, Álvarez-Maestro M, Servan PP, De La Cruz SMP, Perez MPS, Máximo V, Soares P

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study. Frontiers in genetics 10: 1237, 2019.  [Article] 

 doi: 10.3389/fgene.2019.01237 PMID: 31921291.

 

79. Cavadas B, Pereira JB, Correia M, Fernandes V, Eloy C, Sobrinho-Simões M, Soares P, Samuels DC, Máximo V, Pereira L

Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background. Mitochondrion 46: 123-133, 2019.  [Article] 

 doi: 10.1016/j.mito.2018.04.001 PMID: 29631022.

 

80. Boaventura P, Pereira D, Mendes A, Batista R, da Silva AF, Guimarães I, Honavar M, Teixeira-Gomes J, Lopes JM, Máximo V, Soares P

Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas. Journal of dermatological science 73: 31-9, 2014.  [Article] 

 doi: 10.1016/j.jdermsci.2013.09.002 PMID: 24091058.

 

81. Trovisco V, Couto JP, Cameselle-Teijeiro J, de Castro IV, Fonseca E, Soares P, Sobrinho-Simões M

Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma. Clinical endocrinology 69: 683-5, 2008.  [Letter] 

 doi: 10.1111/j.1365-2265.2008.03243.x PMID: 18363883.

 

82. Soares P, Berx G, van Roy F, Sobrinho-Simões M

E-cadherin gene alterations are rare events in thyroid tumors. International journal of cancer 70: 32-8, 1997.  [Article] 

 PMID: 8985087.

 

83. Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC

Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Clinical endocrinology 64: 659-66, 2006.  [Article] 

 doi: 10.1111/j.1365-2265.2006.02524.x PMID: 16712668.

 

84. Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões M

p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 16: 43-8, 2003.  [Article] 

 doi: 10.1097/01.MP.0000047306.72278.39 PMID: 12527712.

 

85. Cameselle-Teijeiro J, Pardal F, Eloy C, Ruiz-Ponte C, Celestino R, Castro P, Soares P, Sobrinho-Simões M

Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth. Human pathology 39: 1540-7, 2008.  [Article] 

 doi: 10.1016/j.humpath.2008.01.014 PMID: 18602667.

 

86. Pestana A, Vinagre J, Sobrinho-Simões M, Soares P

TERT biology and function in cancer: beyond immortalisation. Journal of molecular endocrinology 58: R129-R146, 2017.  [Review] 

 doi: 10.1530/JME-16-0195 PMID: 28057768.

 

87. Celestino R, Nome T, Pestana A, Hoff AM, Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T, Sobrinho-Simões M, Skotheim RI, Soares P

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension. BMC cancer 18: 68, 2018.  [Article] 

 doi: 10.1186/s12885-017-3948-3 PMID: 29321030.

 

88. Bauer J, Weng J, Kebebew E, Soares P, Trovisco V, Bastian BC

Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer. Experimental dermatology 18: 548-52, 2009.  [Article] 

 doi: 10.1111/j.1600-0625.2008.00827.x PMID: 19493000.

 

89. Durães C, Moreira CS, Alvelos I, Mendes A, Santos LR, Machado JC, Melo M, Esteves C, Neves C, Sobrinho-Simões M, Soares P

Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease. PloS one 9: e105492, 2014.  [Article] 

 doi: 10.1371/journal.pone.0105492 PMID: 25127106.

 

90. Gaspar TB, Sá A, Lopes JM, Sobrinho-Simões M, Soares P, Vinagre J

Telomere Maintenance Mechanisms in Cancer. Genes 9: ., 2018.  [Review] 

 doi: 10.3390/genes9050241 PMID: 29751586.

 

91. Lima AR, Santos L, Correia M, Soares P, Sobrinho-Simões M, Melo M, Máximo V

Dynamin-Related Protein 1 at the Crossroads of Cancer. Genes 9: ., 2018.  [Review] 

 doi: 10.3390/genes9020115 PMID: 29466320.

 

92. Penna GC, Pestana A, Cameselle JM, Momesso D, de Andrade FA, Vidal APA, Araujo Junior ML, Melo M, Fernandes PV, Corbo R, Vaisman M, Sobrinho-Simões M, Soares P, Vaisman F

TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma. Endocrine 61: 489-498, 2018.  [Article] 

 doi: 10.1007/s12020-018-1642-0 PMID: 29948935.

 

93. Alves C, Silva F, Gusmão L, Seruca R, Soares P, Reis RM, Amorim A

Extended structural variation of a pentanucleotide repeat in the GSTP1 gene: characterisation in a normal population and in thyroid and gastric tumours. European journal of human genetics : EJHG 8: 540-4, 2000.  [Article] 

 doi: 10.1038/sj.ejhg.5200486 PMID: 10909855.

 

94. Ferreira-da-Silva A, Valacca C, Rios E, Pópulo H, Soares P, Sobrinho-Simões M, Scorrano L, Máximo V, Campello S

Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. PloS one 10: e0122308, 2015.  [Article] 

 doi: 10.1371/journal.pone.0122308 PMID: 25822260.

 

95. Lima J, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simões M

Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer letters 230: 149-50, 2005.  [Letter] 

 doi: 10.1016/j.canlet.2004.10.053 PMID: 16253771.

 

96. Tavares C, Coelho MJ, Eloy C, Melo M, da Rocha AG, Pestana A, Batista R, Ferreira LB, Rios E, Selmi-Ruby S, Cavadas B, Pereira L, Sobrinho Simões M, Soares P

NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features. Endocrine connections 7: 78-90, 2018.  [Article] 

 doi: 10.1530/EC-17-0302 PMID: 29298843.

 

97. Martins-Mendes D, Monteiro-Soares M, Boyko EJ, Ribeiro M, Barata P, Lima J, Soares R

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. Journal of diabetes and its complications 28: 632-8, 2014.  [Article] 

 doi: 10.1016/j.jdiacomp.2014.04.011 PMID: 24877985.

 

98. Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D

Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas. Journal of cellular biochemistry 118: 2064-2071, 2017.  [Article] 

 doi: 10.1002/jcb.25811 PMID: 27886397.

 

99. Rocha AS, Soares P, Fonseca E, Cameselle-Teijeiro J, Oliveira MC, Sobrinho-Simões M

E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 42: 580-7, 2003.  [Article] 

 PMID: 12786894.

 

100. Cameselle-Teijeiro J, Abdulkader I, Soares P, Alfonsín-Barreiro N, Moldes-Boullosa J, Sobrinho-Simões M

Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid. American journal of clinical pathology 123: 369-75, 2005.  [Article] 

 doi: 10.1309/GWT2-PY0T-77PB-BA1A PMID: 15716232.

 

101. Canberk S, Pereira L, Batista R, Soares P, Maximo V, Simoes MS

DICER1 alterations are more frequent in oncocytic, follicular and rare aggressive variants than in classical papillary thyroid carcinoma Virchows Archiv 473: S67-S67, 2018.  [Meeting Abstract] 

.

 

102. Berto-Júnior C, Santos-Silva AP, Ferreira ACF, Graceli JB, de Carvalho DP, Soares P, Romeiro NC, Miranda-Alves L

Unraveling molecular targets of bisphenol A and S in the thyroid gland. Environmental science and pollution research international 25: 26916-26926, 2018.  [Article] 

 doi: 10.1007/s11356-018-2419-y PMID: 30006815.

 

103. Pópulo H, Vinagre J, Lopes JM, Soares P

Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas. The British journal of ophthalmology 95: 715-9, 2011.  [Article] 

 doi: 10.1136/bjo.2009.174417 PMID: 20805136.

 

104. Soares P, Sobrinho-Simões M

Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998. Clinical cancer research : an official journal of the American Association for Cancer Research 5: 3724-5, 1999.  [Letter] 

 PMID: 10589793.

 

105. Cameselle-Teijeiro J, Ferreira R, Caramés N, Abdulkader I, Máximo V, Soares P, Sobrinho-Simões M

Absence of the BRAF and the GRIM-19 Mutations in Oncocytic (Hurthle Cell) Solid Cell Nests of the Thyroid. American journal of clinical pathology 137: 612-8, 2012.  [Article] 

 doi: 10.1309/AJCPB0RXYPACLL5K PMID: 22431538.

 

106. Lima RT, Seca H, Soares P, Nascimento MS, Vasconcelos MH

EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide. Journal of cellular biochemistry 112: 200-10, 2011.  [Article] 

 doi: 10.1002/jcb.22920 PMID: 21069730.

 

107. Trovisco V, Soares P, Sobrinho-Simões M

B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Human pathology 37: 781-6, 2006.  [Article] 

 doi: 10.1016/j.humpath.2006.03.013 PMID: 16784975.

 

108. Rocha AS, Risberg B, Magalhães J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simões M

The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma. Human pathology 37: 562-8, 2006.  [Article] 

 doi: 10.1016/j.humpath.2005.12.016 PMID: 16647954.

 

109. Sousa I, Rodrigues F, Prazeres H, Lima RT, Soares P

Liposomal therapies in oncology: does one size fit all? Cancer chemotherapy and pharmacology 82: 741-755, 2018.  [Review] 

 doi: 10.1007/s00280-018-3668-7 PMID: 30116847.

 

110. Boaventura P, Durães C, Mendes A, Costa NR, Chora I, Ferreira S, Araújo E, Lopes P, Rosa G, Marques P, Bettencourt P, Oliveira I, Costa F, Ramos I, Teles MJ, Guimarães JT, Sobrinho-Simões M, Soares P

IL6-174 G>C Polymorphism (rs1800795) Association with Late Effects of Low Dose Radiation Exposure in the Portuguese Tinea Capitis Cohort. PloS one 11: e0163474, 2016.  [Article] 

 doi: 10.1371/journal.pone.0163474 PMID: 27662210.

 

111. Pópulo H, Batista R, Sampaio C, Pardal J, Lopes JM, Soares P

SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma. PloS one 12: e0180392, 2017.  [Article] 

 doi: 10.1371/journal.pone.0180392 PMID: 28662141.

 

112. Canberk S, Montezuma D, Tastekin E, Grangeia D, Demirhas MP, Akbas M, Tokat F, Ince U, Soares P, Schmitt F

"The other side of the coin": understanding noninvasive follicular tumor with papillary-like nuclear features in unifocal and multifocal settings. Human pathology 86: 136-142, 2019.  [Article] 

 doi: 10.1016/j.humpath.2018.10.040 PMID: 30529753.

 

113. Preto A, Gonçalves J, Rebocho AP, Figueiredo J, Meireles AM, Rocha AS, Vasconcelos HM, Seca H, Seruca R, Soares P, Sobrinho-Simões M

Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC cancer 9: 387, 2009.  [Article] 

 doi: 10.1186/1471-2407-9-387 PMID: 19878585.

 

114. Máximo V, Soares P, Seruca R, Sobrinho-Simões M

Comments on: mutations in mitochondrial control region DNA in gastric tumours of Japanese patients, Tamura, et al. Eur J Cancer 1999, 35, 316-319. European journal of cancer (Oxford, England : 1990) 35: 1407-8, 1999.  [Letter] 

 PMID: 10658535.

 

115. Meireles AM, Preto A, Rocha AS, Rebocho AP, Máximo V, Pereira-Castro I, Moreira S, Feijão T, Botelho T, Marques R, Trovisco V, Cirnes L, Alves C, Velho S, Soares P, Sobrinho-Simões M

Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid : official journal of the American Thyroid Association 17: 707-15, 2007.  [Article] 

 doi: 10.1089/thy.2007.0097 PMID: 17725429.

 

116. Eloy C, Santos J, Cameselle-Teijeiro J, Soares P, Sobrinho-Simões M

TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma. Virchows Archiv : an international journal of pathology 460: 587-600, 2012.  [Article] 

 doi: 10.1007/s00428-012-1234-y PMID: 22527019.

 

117. Vinagre J, Pópulo H, Azevedo F, Soares P, Lopes JM

 Expression of pS6 Ser235/236 effector of mTOR pathway may be a prognostic parameter in patients with cutaneous melanomas Virchows Archiv  1, 2012.  [Meeting Abstract] 

.

 

118. Vinagre J, Falcão M, Eloy C, Soares P, Lopes JM

A clear cell renal carcinoma causing resistance to VEGF inhibitors in an age-related macular degeneration (AMD)? Virchows Archiv  S49, 2012.  [Meeting Abstract] 

.

 

119. Camesell-Teijeiro J, Celestino R, Veiga A, Eloy C, Abdulkader I, Reyes R, Soares P, Sobrinho Simões M

Carcinoma showing thymus-like elements (CASTLE) of the thyroid: case report with immunohistochemical and molecular study Virchows Archiv  461, 2012.  [Meeting Abstract] 

.

 

120. Vinagre J, Celestino R, Gouveia A, Lima J, Faustino A, Soares P

A novel germline SDHB mutation in a GIST patient without associated paraganglioma or pheochromocytoma Virchows Archiv 459: S326-S326, 2012.  [Meeting Abstract] 

.

 

121. Vinagre J, Pinto V, Celestino R, Reis M, Pópulo H, Boaventura P, Melo M, Catarino T, Lima J, Lopes JM, Máximo V, Sobrinho-Simões M, Soares P

Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Archiv : an international journal of pathology 465: 119-33, 2014.  [Review] 

 doi: 10.1007/s00428-014-1608-4 PMID: 25048572.

 

122. Soares P, Celestino R, Melo M, Fonseca E, Sobrinho-Simões M

Prognostic biomarkers in thyroid cancer. Virchows Archiv : an international journal of pathology 464: 333-46, 2014.  [Review] 

 doi: 10.1007/s00428-013-1521-2 PMID: 24487783.

 

123. Boaventura P, Pereira D, Mendes A, Teixeira-Gomes J, Sobrinho-Simões M, Soares P

Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963). Virchows Archiv : an international journal of pathology 465: 445-52, 2014.  [Article] 

 doi: 10.1007/s00428-014-1644-0 PMID: 25146169.

 

124. Cameselle-Teijeiro J, Ladra MJ, Abdulkader I, Eloy C, Soares P, Barreiro F, Sobrinho-Simões M, Beiras-Iglesias A

Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease). Virchows Archiv : an international journal of pathology 465: 359-64, 2014.  [Article] 

 doi: 10.1007/s00428-014-1626-2 PMID: 25011997.

 

125. Rocha AS, Marques R, Bento I, Soares R, Magalhães J, de Castro IV, Soares P

Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas. The Journal of endocrinology 192: 83-6, 2007.  [Article] 

 doi: 10.1677/JOE-06-0009 PMID: 17210745.

 

126. Vazquez Vde L, Vicente AL, Carloni A, Berardinelli G, Soares P, Scapulatempo C, Martinho O, Reis RM

Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas. Melanoma research 26: 93-9, 2016.  [Article] 

 doi: 10.1097/CMR.0000000000000222 PMID: 26709572.

 

127. Cameselle-Teijeiro J, Ferreira R, Caramés N, Abdulkader I, Máximo V, Soares P, Sobrinho-Simões M

Absence of both the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid American journal of clinical pathology  1, 2011.  [] 

.

 

128. Pópulo H, Nunes B, Sampaio C, Batista R, Pinto MT, Gaspar TB, Miranda-Alves L, Cai RZ, Zhang XY, Schally AV, Sobrinho-Simões M, Soares P

Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer. Hormones & cancer 8: 314-324, 2017.  [Article] 

 doi: 10.1007/s12672-017-0307-4 PMID: 28924876.

 

129. Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M

A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Human pathology 36: 694-7, 2005.  [Article] 

 doi: 10.1016/j.humpath.2005.04.011 PMID: 16021577.

 

130. Cameselle-Teijeiro J, Preto A, Soares P, Sobrinho-Simões M

A stem cell role for thyroid solid cell nests. Human pathology 36: 590-1, 2005.  [Letter] 

 doi: 10.1016/j.humpath.2005.02.010 PMID: 15948129.

 

131. Boaventura P, Durães C, Mendes A, Costa NR, Chora I, Ferreira S, Araújo E, Lopes P, Rosa G, Marques P, Tavares S, Chaves V, Bettencourt P, Oliveira I, Costa F, Ramos I, Teles MJ, Guimarães JT, Sobrinho-Simões M, Soares P

Is Low-Dose Radiation Exposure a Risk Factor for Atherosclerotic Disease? Radiation research 189: 418-424, 2018.  [Article] 

 doi: 10.1667/RR14942.1 PMID: 29461943.

 

132. Basto D, Trovisco V, Lopes JM, Martins A, Pardal F, Soares P, Reis RM

Mutation analysis of B-RAF gene in human gliomas. Acta neuropathologica 109: 207-10, 2005.  [Article] 

 doi: 10.1007/s00401-004-0936-x PMID: 15791479.

 

133. Gonçalves AP, Videira A, Soares P, Máximo V

Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR. Life sciences 89: 371-7, 2011.  [Article] 

 doi: 10.1016/j.lfs.2011.07.004 PMID: 21807000.

 

134. Eloy C, Santos J, Soares P, Sobrinho-Simões M

The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Virchows Archiv : an international journal of pathology 459: 265-76, 2011.  [Article] 

 doi: 10.1007/s00428-011-1133-7 PMID: 21796448.

 

135. Eloy C, Santos J, Soares P, Sobrinho-Simões M

Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Archiv : an international journal of pathology 459: 595-605, 2011.  [Article] 

 doi: 10.1007/s00428-011-1161-3 PMID: 22081104.

 

136. Cameselle-Teijeiro J, Menasce LP, Yap BK, Colaco RJ, Castro P, Celestino R, Ruíz-Ponte C, Soares P, Sobrinho-Simões M

Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. American journal of clinical pathology 131: 134-42, 2009.  [Article] 

 doi: 10.1309/AJCP7ULS0VSISBEB PMID: 19095577.

 

137. Pópulo H, Lopes JM, Soares P

The mTOR Signalling Pathway in Human Cancer. International journal of molecular sciences 13: 1886-918, 2012.  [Review] 

 doi: 10.3390/ijms13021886 PMID: 22408430.

 

138. Gullo I, Batista R, Rodrigues-Pereira P, Soares P, Barroca H, do Bom-Sucesso M, Sobrinho-Simões M

Multinodular Goiter Progression Toward Malignancy in a Case of DICER1 Syndrome: Histologic and Molecular Alterations. American journal of clinical pathology 149: 379-386, 2018.  [Article] 

 doi: 10.1093/ajcp/aqy004 PMID: 29538609.

 

139. Rocha AS, De Wever O, Moreira S, Costa MJ, Vandekerckhove J, Mareel M, Soares P

Mutated E-cadherin: genomic and functional characterization in thyroid cells from the KAT family. Thyroid : official journal of the American Thyroid Association 14: 902-9, 2004.  [Article] 

 doi: 10.1089/thy.2004.14.902 PMID: 15671768.

 

140. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Current genomics 12: 609-17, 2011.  [Article] 

 doi: 10.2174/138920211798120853 PMID: 22654560.

 

141. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Alterations in Poorly Differentiated and Unddiferentiated Thyroid Carcinomas Current genomics  1, 2011.  [] 

.

 

142. Bonin S, Hlubek F, Benhattar J, Denkert C, Dietel M, Fernandez PL, Höfler G, Kothmaier H, Kruslin B, Mazzanti CM, Perren A, Popper H, Scarpa A, Soares P, Stanta G, Groenen PJ

Multicentre validation study of nucleic acids extraction from FFPE tissues. Virchows Archiv : an international journal of pathology 457: 309-17, 2010.  [Article] 

 doi: 10.1007/s00428-010-0917-5 PMID: 20665046.

 

143. Couto JP, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. Journal of clinical pathology 62: 414-21, 2009.  [Review] 

 doi: 10.1136/jcp.2008.055343 PMID: 19147628.

 

144. Bertagnolli AC, Soares P, van Asch B, Amorim A, Cirnes L, Máximo V, Cassali GD

An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Veterinary journal (London, England : 1997) 182: 269-74, 2009.  [Article] 

 doi: 10.1016/j.tvjl.2008.07.005 PMID: 18752974.

 

145. Pignatelli D, Ferreira J, Soares P, Costa MJ, Magalhães MC

Immunohistochemical study of heat shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production. Microscopy research and technique 61: 315-23, 2003.  [Article] 

 doi: 10.1002/jemt.10341 PMID: 12768547.

 

146. Máximo V, Lima J, Soares P, Sobrinho-Simões M

Mitochondria and cancer. Virchows Archiv : an international journal of pathology 454: 481-95, 2009.  [Review] 

 doi: 10.1007/s00428-009-0766-2 PMID: 19343360.

 

147. Máximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simões M

Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC cancer 4: 12, 2004.  [Article] 

 doi: 10.1186/1471-2407-4-12 PMID: 15043758.

 

148. Santos AP, Vinagre J, Soares P, Claro I, Sanches AC, Gomes L, Fernandes I, Catarino AL, Preto J, Pereira BD, Marques AP, Rodrigues F, Amaral C, Rocha G, Mellidez JC, Simões H, Lopes JM, Bugalho MJ, On behalf of the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism MJ

Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism. International journal of endocrinology 2019: 4518742, 2019.  [Article] 

 doi: 10.1155/2019/4518742 PMID: 31467527.

 

149. Pópulo H, Soares P, Rocha AS, Silva P, Lopes JM

Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma. Melanoma research 20: 107-17, 2010.  [Article] 

 doi: 10.1097/CMR.0b013e32832ccd09 PMID: 20173664.

 

150. Soares P, Trovisco V, Rocha AS, Feijão T, Rebocho AP, Fonseca E, Vieira de Castro I, Cameselle-Teijeiro J, Cardoso-Oliveira M, Sobrinho-Simões M

BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Archiv : an international journal of pathology 444: 572-6, 2004.  [Article] 

 doi: 10.1007/s00428-004-1018-0 PMID: 15095090.

 

151. Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Archiv : an international journal of pathology 446: 589-95, 2005.  [Article] 

 doi: 10.1007/s00428-005-1236-0 PMID: 15902486.

 

152. Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P

Molecular pathology of well-differentiated thyroid carcinomas. Virchows Archiv : an international journal of pathology 447: 787-93, 2005.  [Review] 

 doi: 10.1007/s00428-005-0065-5 PMID: 16189702.

 

153. Rodrigues AC, Penna G, Rodrigues E, Castro P, Sobrinho-Simões M, Soares P

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications. Current genomics 18: 244-254, 2017.  [Review] 

 doi: 10.2174/1389202918666170105094459 PMID: 28659720.

 

154. Sobrinho-Simões M, Máximo V, Rocha AS, Trovisco V, Castro P, Preto A, Lima J, Soares P

Intragenic mutations in thyroid cancer. Endocrinology and metabolism clinics of North America 37: 333-62, viii, 2008.  [Review] 

 doi: 10.1016/j.ecl.2008.02.004 PMID: 18502330.

 

155. Cappagli V, Potes CS, Ferreira LB, Tavares C, Eloy C, Elisei R, Sobrinho-Simões M, Wookey PJ, Soares P

Calcitonin receptor expression in medullary thyroid carcinoma. PeerJ 5: e3778, 2017.  [Article] 

 doi: 10.7717/peerj.3778 PMID: 28929017.

 

156. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, Lacerda M, Martins TC

Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7: 141-9, 2008.  [Article] 

 doi: 10.1007/s10689-007-9160-x PMID: 17823852.

 

157. Ivanova R, Soares P, Castro P, Sobrinho-Simões M

Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Archiv : an international journal of pathology 440: 418-24, 2002.  [Article] 

 doi: 10.1007/s00428-001-0543-3 PMID: 11956824.

 

158. Rocha AS, Soares P, Machado JC, Máximo V, Fonseca E, Franssila K, Sobrinho-Simões M

Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Archiv : an international journal of pathology 440: 498-504, 2002.  [Article] 

 doi: 10.1007/s00428-002-0622-0 PMID: 12021924.

 

159. Preto A, Moutinho C, Velho S, Oliveira C, Rebocho AP, Figueiredo J, Soares P, Lopes JM, Seruca R

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation. Virchows Archiv : an international journal of pathology 450: 619-26, 2007.  [Article] 

 doi: 10.1007/s00428-007-0420-9 PMID: 17487504.

 

160. Almeida LMCA, Silva R, Cavadas B, Lima J, Pereira L, Soares P, Sobrinho-Simões M, Lopes JM, Máximo V

GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma. Histology and histopathology 32: 1029-1040, 2017.  [Article] 

 doi: 10.14670/HH-11-863 PMID: 28028797.

 

161. Celestino R, Lima J, Faustino A, Máximo V, Gouveia A, Vinagre J, Soares P, Lopes JM

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad. Familial cancer 11: 189-94, 2012.  [Article] 

 doi: 10.1007/s10689-011-9499-x PMID: 22160509.

 

162. Nogueira AM, Marques T, Soares PC, David L, Reis CA, Serpa J, Queiroz DM, Rocha GA, Rocha AC

Lewis antigen expression in gastric mucosa of children: relationship with Helicobacter pylori infection. Journal of pediatric gastroenterology and nutrition 38: 85-91, 2004.  [Article] 

 PMID: 14676601.

 

163. Boaventura P, Oliveira R, Pereira D, Soares P, Teixeira-Gomes J

Head and neck basal cell carcinoma prevalence in individuals submitted to childhood X-ray 1 epilation for tinea capitis treatment European Journal of Dermatology  1, 2012.  [Article] 

 PMID: 22381641.

 

164. Castanheira A, Soares P, Boaventura P

Scalp basal cell carcinoma: A different entity? Dermatologic therapy 32: e12828, 2019.  [Review] 

 doi: 10.1111/dth.12828 PMID: 30659714.

 

165. Castro P, Sansonetty F, Soares P, Dias A, Sobrinho-Simões M

Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern. Virchows Archiv : an international journal of pathology 438: 336-42, 2001.  [Article] 

 PMID: 11355166.

 

166. Goncalves AP, Videira A, Maximo V, Soares P

Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. Journal of biosciences 36: 639-48, 2011.  [Article] 

 PMID: 21857110.

 

167. Fonseca E, Soares P, Cardoso-Oliveira M, Sobrinho-Simões M

Diagnostic criteria in well-differentiated thyroid carcinomas. Endocrine pathology 17: 109-17, 2006.  [Article] 

 PMID: 17159243.

 

168. Vala H, Pópulo H, Mesquita JR, Esteves F, Santos C, Soares P, Lopes JM

Melanocytic tumour in a black sheep never exposed to ultraviolet radiation. Journal of comparative pathology 146: 160-4, 2012.  [Article] 

 doi: 10.1016/j.jcpa.2011.04.001 PMID: 21612790.

 

169. Penna GC, Vaisman F, Vaisman M, Sobrinho-Simões M, Soares P

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes. Cytogenetic and genome research 150: 194-207, 2016.  [Review] 

 doi: 10.1159/000456576 PMID: 28231576.

 

170. Batista R, Gaspar TB, Soares P, Vinagre J

Editorial on "The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma" TRANSLATIONAL CANCER RESEARCH 7: S762-S765, 2018.  [Editorial Material] 

 doi: 10.21037/tcr.2018.08.06.

 

171. Sobrinho-Simões M, Eloy C, Vinagre J, Soares P

Molecular pathology of thyroid tumors: diagnostic and prognostic relevance. International journal of surgical pathology 18: 209S-212S, 2010.  [Article; Proceedings Paper] 

 doi: 10.1177/1066896910370886 PMID: 20484293.

 

172. Prazeres H, Torres J, Soares P, Sobrinho-Simões M

The familial counterparts of follicular cell--derived thyroid tumors. International journal of surgical pathology 18: 233-42, 2010.  [Review] 

 doi: 10.1177/1066896910366442 PMID: 20444727.

 

173. Sobrinho-Simões M, Magalhães J, Soares P

Hot topics in papillary thyroid carcinoma. International journal of surgical pathology 18: 190S-193S, 2010.  [Article; Proceedings Paper] 

 doi: 10.1177/1066896910370882 PMID: 20484289.

 

174. Eloy C, Vinagre J, Cameselle-Teijeiro J, Paiva ME, Soares P, Sobrinho-Simões M

Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component? International journal of surgical pathology 19: 276-80, 2011.  [Article] 

 doi: 10.1177/1066896910393506 PMID: 21216781.

 

175. Nakazawa T, Celestino R, Machado JC, Cameselle-Teijeiro JM, Vinagre J, Eloy C, Benserai F, Lameche S, Soares P, Sobrinho-Simões M

Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. International journal of surgical pathology 21: 379-89, 2013.  [Article] 

 doi: 10.1177/1066896912473355 PMID: 23349472.

 

176. Soares P, Celestino R, Gaspar da Rocha A, Sobrinho-Simões M

Papillary Thyroid Microcarcinoma: How to Diagnose and Manage this Epidemic? International journal of surgical pathology 22: 113-9, 2014.  [Article] 

 doi: 10.1177/1066896913517394 PMID: 24401191.

 

177. Nakazawa T, Cameselle-Teijeiro J, Vinagre J, Soares P, Rousseau E, Eloy C, Sobrinho-Simões M

C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity. International journal of surgical pathology 22: 530-5, 2014.  [Article] 

 doi: 10.1177/1066896914525228 PMID: 24599901.

 

178. Castro P, David L, Soares P, Carneiro F, Fonseca E, Sobrinho-Simões M

Vascular invasion in thyroid and gastric carcinomas. Ultrastructural pathology 27: 41-8, 2003.  [Article; Proceedings Paper] 

 PMID: 12554535.

 

179. Sobrinho-Simões M, Máximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC

Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. International journal of surgical pathology 13: 29-35, 2005.  [Review] 

 PMID: 15735852.

 

180. Preto A, Reis-Filho JS, Ricardo S, Soares P

P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression. Pathology, research and practice 198: 449-54, 2002.  [Article] 

 PMID: 12234063.

 

181. Máximo V, Lima J, Soares P, Botelho T, Gomes L, Sobrinho-Simões M

Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion 5: 333-40, 2005.  [Article] 

 doi: 10.1016/j.mito.2005.06.003 PMID: 16183030.

 

182. Sobrinho-Simões M, Sambade C, Fonseca E, Soares P

Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. International journal of surgical pathology 10: 123-31, 2002.  [Article] 

 PMID: 12075405.

 

183. Alves P, Soares P, Rossi S, Fonseca E, Sobrinho-Simões M

Clinicopathologic and Prognostic Significance of the Expression of Mucins, Simple Mucin Antigens and Histo-Blood Group Antigens in Papillary Thyroid Carcinoma. Endocrine pathology 10: 305-313, 1999.  [Article] 

 PMID: 12114767.

 

184. Alves P, Soares P, Fonseca E, Sobrinho-Simões M

Papillary Thyroid Carcinoma Overexpresses Fully and Underglycosylated Mucins Together with Native and Sialylated Simple Mucin Antigens and Histo-Blood Group Antigens. Endocrine pathology 10: 315-324, 1999.  [Article] 

 PMID: 12114768.

 

185. Alvarenga CA, Lopes JM, Vinagre J, Paravidino PI, Alvarenga M, Prando A, Castilho LN, Soares P, Billis A

Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review. São Paulo medical journal = Revista paulista de medicina 130: 57-60, 2012.  [Article] 

 PMID: 22344361.

 

186. Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simões M

E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Laboratory investigation; a journal of technical methods and pathology 79: 459-65, 1999.  [Article] 

 PMID: 10211998.

 

187. Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simões M

Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? The Journal of pathology 185: 71-8, 1998.  [Article] 

 doi: 10.1002/(SICI)1096-9896(199805)185:1<71::AID-PATH42>3.0.CO;2-S PMID: 9713362.

 

188. Soares P, Cameselle-Teijeiro J, Sobrinho-Simões M

Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 24: 205-10, 1994.  [Article] 

 PMID: 8200621.

 

189. Seruca R, Castedo S, Correia C, Gomes P, Carneiro F, Soares P, de Jong B, Sobrinho-Simões M

Cytogenetic findings in eleven gastric carcinomas. Cancer genetics and cytogenetics 68: 42-8, 1993.  [Article] 

 PMID: 8330282.

 

190. David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M

c-erbB-2 expression in primary gastric carcinomas and their metastases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 5: 384-90, 1992.  [Article] 

 PMID: 1353880.

 

191. Roque L, Castedo S, Gomes P, Soares P, Clode A, Soares J

Cytogenetic findings in 18 follicular thyroid adenomas. Cancer genetics and cytogenetics 67: 1-6, 1993.  [Article] 

 PMID: 8504394.

 

192. Domingues B, Lopes JM, Soares P, Pópulo H

Melanoma treatment in review. ImmunoTargets and therapy 7: 35-49, 2018.  [Review] 

 doi: 10.2147/ITT.S134842 PMID: 29922629.

 

193. Soares P, dos Santos NR, Seruca R, Lothe RA, Sobrinho-Simões M

Benign and malignant thyroid lesions show instability at microsatellite loci. European journal of cancer (Oxford, England : 1990) 33: 293-6, 1997.  [Article] 

 PMID: 9135503.

 

194. Máximo V, Sores P, Rocha AS, Sobrinho-Simões M

The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastructural pathology 22: 271-3, 1998.  [Letter] 

 PMID: 9793208.

 

195. Soares P, Sobrinho-Simões M

Recent advances in cytometry, cytogenetics and molecular genetics of thyroid tumours and tumour-like lesions. Pathology, research and practice 191: 304-17, 1995.  [Article; Proceedings Paper] 

 PMID: 7479347.

 

196. Carneiro F, Moutinho-Ribeiro M, David L, Seixas M, Sansonetty F, Soares P, Serrano A, Sobrinho-Simões M

Signet ring cell carcinoma of the stomach: a morphometric, ultrastructural, and DNA cytometric study. Ultrastructural pathology 16: 603-14, 1992.  [Article] 

 PMID: 1333109.

 

197. Roque L, Gomes P, Correia C, Soares P, Soares J, Castedo S

Thyroid nodular hyperplasia: chromosomal studies in 14 cases. Cancer genetics and cytogenetics 69: 31-4, 1993.  [Article] 

 PMID: 8374896.

 

198. Trovisco V, Soares P, Preto A, Castro P, Máximo V, Sobrinho-Simões M

Molecular genetics of papillary thyroid carcinoma: great expectations. Arquivos brasileiros de endocrinologia e metabologia 51: 643-53, 2007.  [Review] 

 PMID: 17891228.

 

199. Castedo S, Correia C, Gomes P, Seruca R, Soares P, Carneiro F, Sobrinho-Simões M

Loss of Y chromosome in gastric carcinoma. Fact or artifact? Cancer genetics and cytogenetics 61: 39-41, 1992.  [Article] 

 PMID: 1638479.

 

200. Soares P, Sambade C, Sobrinho-Simões M

Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid. International journal of cancer 56: 459-61, 1994.  [Letter] 

 PMID: 7906256.

 

201. Soares P, Sobrinho-Simöes M

Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer 73: 2879-81, 1994.  [Letter] 

 PMID: 7910779.

 

202. Seruca R, Carneiro F, Soares P, Fonseca E, Castedo S

Clonal cytogenetic abnormalities and telomeric associations in a fibroxanthoma of the stomach. Genes, chromosomes & cancer 5: 407-9, 1992.  [Note] 

 PMID: 1283331.

 

203. Pópulo H, Tavares S, Faustino A, Nunes JB, Lopes JM, Soares P

GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells. PeerJ 1: e104, 2013.  [Article] 

 doi: 10.7717/peerj.104 PMID: 23904987.

 

204. Fonseca E, Soares P, Rossi S, Sobrinho-Simões M

[Prognostic factors in differentiated thyroid gland carcinoma] Der Pathologe 18: 275-85, 1997.  [Review] 

 PMID: 9380603.

 

205. Soares P, Sobrinho-Simões M

Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer? Future oncology (London, England) 5: 1225-9, 2009.  [Article] 

 doi: 10.2217/fon.09.81 PMID: 19852736.

 

206. Cameselle-Teijeiro JM, Eloy C, Amendoeira I, Soares P, Carneiro-Gómez J, Melo M, Sobrinho-Simões M

Rare familial tumours Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification  57-77, 2017.  [] 

 doi: 10.1007/978-3-319-61182-2_5.

 

207. Prazeres H, Torres J, Rodrigues F, Couto JP, Vinagre J, Sobrinho-Simões M, Soares P

How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer. Journal of thyroid research 2011: 678357, 2011.  [] 

 doi: 10.4061/2011/678357 PMID: 21765992.

 

208. Eloy C, Soares P, Máximo V, Sobrinho-Simões M

Thyroid and parathyroid glands Pathology of the Head and Neck  613-671, 2017.  [] 

 doi: 10.1007/978-3-662-49672-5_14.

 

209. Prazeres H, Salgado C, Duarte C, Soares P

LRP1B (low density lipoprotein receptor-related protein 1B) Atlas Genet Cytogenet Oncol Haematol  ., 2013.  [] 

.

 

210. Soares P, Máximo V, Sobrinho-Simöes M

Molecular pathology of papillary, follicular and Hürthle cell carcinomas of the thyroid. Arkhiv patologii 65: 45-7, 2003.  [] 

 PMID: 15357248.

 

211. Sobrinho-Simões M, Eloy C, Amendoeira I, Soares P, Caneiro-Gómez J, Melo M, Cameselle-Teijeiro JM

Introduction Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification  1-4, 2017.  [] 

 doi: 10.1007/978-3-319-61182-2_1.

 

212. Melo M, Vicente N, Ventura M, da Rocha AG, Soares P, Carrilho F

The role of ablative treatment in differentiated thyroid cancer management Expert Review of Endocrinology & Metabolism 12: 109-116, 2017.  [Review] 

 doi: 10.1080/17446651.2017.1289839.

 

213. Falcão Manuel S., Vinagre J, Soares P, Lopes JM, Brandão E, Carneiro Ângela M.

A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease Case Rep Ophthalmol  1, 2012.  [] 

 doi: 10.1159/000346045.

 

214. Fonseca E, Soares P, Rossi S, Sobrinho-Simões M

Prognostic factors in thyroid carcinomas. Verhandlungen der Deutschen Gesellschaft für Pathologie 81: 82-96, 1997.  [] 

 PMID: 9474858.

 

215. Preto A, Soares P, Sobrinho-Simões M

Novas terapêuticas no carcinoma da tireóide: novos alvos moleculares? Mundo Médico 54: 8-12, 2007.  [] 

.

 

216. Sobrinho-Simões M, Carneiro F, David L, Soares P, Seruca R

A proeminência da morfologia e a quasi-futilidade das análises genéticas e moleculares no dia-a-dia da patologia oncológica. Revista da Faculdade de Medicina de Lisboa 4:  93-102, 1999.  [] 

.

 

217. Lopes JM, Seruca R, Soares P, Castro-Correia J, Castedo S

Adenoma of the ciliary body- A pathologic and cytogenetic study Cancer genetics and cytogenetics 63: 177, 1992.  [] 

 doi: 10.1016/0165-4608(92)90531-C.

 

218. Eloy C, Cameselle-Teijeiro JM, Amendoeira I, Soares P, Caneiro-Gómez J, Melo M, Sobrinho-Simões M

Small cell tumours Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification  45-56, 2017.  [] 

 doi: 10.1007/978-3-319-61182-2_4.

 

219. Almeida A L, Boaventura M P, Soares P

Etiopathogenic factors of thyroid cancer Clinical Management of Thyroid Cancer  46-62, 2013.  [] 

 doi: 10.2217/ebo.13.37.

 

220. Bertagnolli AC, Máximo V, Van Asch B, Amorim A, Cirnes L, Soares P, Cassali GD

Optimization of methods to assess mitochondrial DNA in archival paraffin-embedded tissues from mammary canine tumors Jornal  Brasileiro de  Patologia  305-308, 2008.  [] 

.

 

221. Cameselle-Teijeiro JM, Eloy C, Amendoeira I, Soares P, Caneiro-Gómez J, Melo M, Sobrinho-Simões M

Rare papillary thyroid carcinomas Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification  5-25, 2017.  [] 

 doi: 10.1007/978-3-319-61182-2_2.

 

222. Linhares P, Martinho O, Carvalho B, Castro L, Lopes JM, Vaz R, Reis RM

Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature. Surgical neurology international 4: 151, 2013.  [] 

 doi: 10.4103/2152-7806.122229 PMID: 24381794.

 

223. Boaventura MP, Pereira D, Teixeira Gomes J, Soares P

Radiation Treatment and Alopecia – Past and Present Concerns Radiation Treatment and Alopecia – Past and Present Concerns  1-22, 2012.  [] 

.

 

224. Melo M, Costa G, Carrilho F, Soares P

Radiotherapy: radioiodine and external beam irradiation treatment of differentiated thyroid carcinomas Clinical Management of Thyroid Cancer  78-92, 2013.  [] 

.

 

225. Roque L, Soares J, Soares P, Castedo S

Genetic markers in thyroid tumors. Surgery 113: 595-8, 1993.  [Letter] 

 PMID: 8488484.

 

226. Cameselle-Teijeiro JM, Eloy C, Amendoeira I, Soares P, Caneiro-Gómez J, Melo M, Sobrinho-Simões M

Other Rare Tumours and Tumour-Like Lesions Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification  79-105, 2017.  [] 

 doi: 10.1007/978-3-319-61182-2_6.

 

227. Eloy C, Ferreira L, Salgado C, Soares P, Sobrinho-Simões M

Poorly Differentiated and Undifferentiated Thyroid Carcinomas. Tu¨rk patoloji dergisi 31 Suppl 1: 48-59, 2015.  [Article] 

 doi: 10.5146/tjpath.2015.01314 PMID: 26177317.

 

228. Melo M, Cameselle-Teijeiro JM, Eloy C, Amendoeira I, Soares P, Caneiro-Gómez J, Sobrinho-Simões M

Therapeutic options Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification  107-110, 2017.  [] 

 doi: 10.1007/978-3-319-61182-2_7.

 

229. Alvelos MI, Mendes M, Soares P

Molecular Alterations in Sporadic Primary Hyperparathyroidism Genetics Research International volume 2011  1, 2011.  [] 

 doi: 10.4061/2011/275802.